We are live on
!
Find out more
N
Natixis Portfolio holdings
AUM
$28B
1-Year Est. Return
26.79%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Fund
S&P 500
This Quarter
Est. Return
-2.18%
1 Year Est. Return
+26.79%
3 Year Est. Return
+97.72%
5 Year Est. Return
+108.83%
10 Year Est. Return
+452.99%
AUM
$13.1B
AUM Growth
+$754M
(+6.1%)
Cap. Flow
+$1.16B
Cap. Flow
% of AUM
8.89%
Top 10 Holdings %
Top 10 Hldgs %
38.02%
Holding
1,188
New
182
Increased
340
Reduced
340
Closed
221
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$379M |
| 2 |
NVIDIA
NVDA
|
+$323M |
| 3 |
Amazon
AMZN
|
+$133M |
| 4 |
UnitedHealth
UNH
|
+$97.5M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$86.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$89.2M |
| 2 |
ExxonMobil
XOM
|
+$83.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$83.1M |
| 4 |
CVS Health
CVS
|
+$82.2M |
| 5 |
Eli Lilly
LLY
|
+$66.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.23% |
| 2 | Healthcare | 11.42% |
| 3 | Energy | 7.9% |
| 4 | Consumer Discretionary | 6.67% |
| 5 | Financials | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Paylocity
PCTY
$6.71B
| $952K | 0.01% |
5,238
+2,915
| +125% | +$585K |
|
|
CUK
502
DELISTED
Carnival PLC
CUK
| $949K | 0.01% |
+77,508
| New | +$1.16M |
|
503
Hercules Capital
HTGC
$2.94B
| $948K | 0.01% |
57,757
+4,900
| +9% | +$80.2K |
|
504
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$427M
| $946K | 0.01% |
42,046
+1,226
| +3% | +$28.8K |
|
505
The Mosaic Company
MOS
$7.09B
| $930K | 0.01% |
26,128
-96,764
| -79% | -$3.71M |
|
506
Liberty Energy
LBRT
$2.83B
| $926K | 0.01% |
50,000
-15,000
| -23% | -$247K |
|
507
Invesco Variable Rate Investment Grade ETF
VRIG
$1.77B
| $925K | 0.01% |
37,065
-1,428
| -4% | -$35.7K |
|
508
Steel Dynamics
STLD
$35.6B
| $919K | 0.01% |
8,575
+4,472
| +109% | +$466K |
|
509
Nasdaq
NDAQ
$51.5B
| $903K | 0.01% |
18,583
-2,849
| -13% | -$144K |
|
510
Terex
TEX
$7.98B
| $880K | 0.01% |
15,271
+5,600
| +58% | +$334K |
|
511
BorgWarner
BWA
$13.2B
| $879K | 0.01% |
21,769
-2,117
| -9% | -$89.7K |
|
512
Liberty Live Group Series C
LLYVK
$9.11B
| $874K | 0.01% |
+27,232
| New | +$902K |
|
513
Essex Property Trust
ESS
$18.9B
| $871K | 0.01% |
4,107
+176
| +4% | +$41.3K |
|
514
iShares US Aerospace & Defense ETF
ITA
$14.2B
| $867K | 0.01% |
8,172
| – | – |
|
515
Belden
BDC
$4B
| $867K | 0.01% |
8,979
+8,747
| +3,770% | +$817K |
|
516
Jack Henry & Associates
JKHY
$10.7B
| $856K | 0.01% |
5,663
-347
| -6% | -$56K |
|
517
Everest Group
EG
$15.2B
| $847K | 0.01% |
2,279
-354
| -13% | -$128K |
|
518
Labcorp
LH
$24.3B
| $842K | 0.01% |
4,190
-7,294
| -64% | -$1.54M |
|
519
Dow Inc
DOW
$21.6B
| $841K | 0.01% |
16,302
-38,304
| -70% | -$2.06M |
|
520
BridgeBio Pharma
BBIO
$16.5B
| $839K | 0.01% |
31,800
+25,800
| +430% | +$732K |
|
521
McCormick & Company Non-Voting
MKC
$13.4B
| $831K | 0.01% |
10,987
+868
| +9% | +$72.5K |
|
522
EPR Properties
EPR
$4.86B
| $821K | 0.01% |
19,776
+12,876
| +187% | +$567K |
|
523
Corteva
CTVA
$59.7B
| $813K | 0.01% |
15,895
-142,723
| -90% | -$7.56M |
|
524
DuPont de Nemours
DD
$18.6B
| $811K | 0.01% |
8,658
-185,389
| -96% | -$17.4M |
|
525
Invesco S&P 500 Pure Growth ETF
RPG
$2.04B
| $809K | 0.01% |
26,703
-157
| -0.6% | -$4.86K |
|
Similar funds
TWC
FDCDDQ
PCH
NA
Natixis's Q3 2023 Portfolio in Review
As of Q3 2023, Natixis held 1,188 positions worth $13.1B, up 6.1% from $12.3B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Natixis deployed $1.16B of net new capital in Q3 2023, opening 182 new positions and adding to 340 existing holdings. Its largest new stake was Oneok: 965,015 shares worth $61.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 21% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $89.2M trimmed.
- Natixis's largest Q3 2023 buy was Oneok: 965,015 shares worth $61.2M.
- Natixis added most to Apple in Q3 2023, an estimated $379M increase.
- Natixis's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $89.2M.
- Natixis fully exited Bristol-Myers Squibb in Q3 2023, selling an estimated $83.1M.
- Natixis's ten largest holdings make up 38% of its $13.1B portfolio in Q3 2023.
- Natixis opened 182 new positions and closed 221 in Q3 2023.
- Natixis's portfolio value rose 6.1% quarter-over-quarter to $13.1B.
Based on Natixis's 13F filing for Q3 2023, filed 14 Nov 2023.